Weight-Loss Compound for Gut Microbiota Ratio Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for overweight and obesity, such as dietary therapy, exercise, and medications, are often unsustainable and have adverse side effects, while surgical procedures are costly and uncertain, necessitating a safer and more effective approach for weight loss and gut microbiota improvement.
Innovation Solution
A compound with the structure of Formula (I), such as Monascinol, is developed to enhance Bacteroidales abundance and reduce the Firmicutes to Bacteroidetes ratio, formulated into compositions for weight loss and gut microbiota improvement, which can be administered orally in various forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Weight of moving object
If dietary therapy and exercise are used for weight loss, then weight loss can be achieved, but the treatments are often unsustainable and have unsatisfactory effectiveness
Solution Approach 1:
The patent introduces a compound that changes the physiological parameters related to gut microbiota composition, specifically affecting the Firmicutes to Bacteroidetes ratio. This biochemical parameter change provides a new mechanism for weight loss that does not rely on unsustainable dietary restrictions or exercise regimens, thereby improving treatment reliability and sustainability.
2Weight of moving object
If medications such as metabolic stimulants, appetite suppressants or starch blockers are used, then weight loss can be achieved, but they cause adverse effects on the patient's body
Solution Approach 1:
The patent identifies and utilizes the beneficial effects of specific gut bacteria (Bacteroidales) that are naturally present in the human microbiota. Instead of using harmful medications to force weight loss, the invention leverages the body's existing beneficial microbial components, converting a natural physiological process into a therapeutic advantage without introducing harmful substances.
Solution Approach 2:
The compound acts as an intermediary substance that modulates the interaction between the host and gut microbiota. It specifically enhances the abundance of Bacteroidales, which then mediate the weight loss effect through improved gut microbiota composition, avoiding the need for direct pharmacological intervention that causes adverse effects.
3Weight of moving object
If surgical procedures such as liposuction, gastrectomy or gastric bypass are used, then weight loss can be achieved, but they have higher costs and uncertainty for obesity patients
Solution Approach 1:
The patent replaces mechanical surgical interventions with a biochemical approach. Instead of using surgery to physically remove or bypass portions of the digestive system, the invention uses a compound that chemically modulates gut microbiota composition, specifically increasing Bacteroidales abundance. This substitution eliminates surgical risks, costs, and recovery requirements while achieving weight loss through biological mechanisms.
Data Source
AI summary
The present invention provides a compound of Formula (I), which can be used to prepare a composition for losing weight and improving gut microbiota composition. The invention also provides a composition comprising an effective amount of the compound, which has the ability to increase the abundance of Bacteroidales, thereby reducing the ratio of Firmicutes to Bacteroidetes, and can increase the abundance of beneficial gut bacteria and change the gut microbiota composition. The compound and composition of the invention can be applied in food, medicine, feed, nutritional supplements and other uses.